6TQ1
N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 5-(1-(1,3-dimethoxypropan-2-yl)-5-morpholino-1H-benzo[d]imidazol-2-yl)-1,3-dimethylpyridin-2(1H)-one
This is a non-PDB format compatible entry.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2009-04-12 |
Detector | RIGAKU SATURN A200 |
Wavelength(s) | 1.54178 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 114.931, 55.606, 68.023 |
Unit cell angles | 90.00, 94.43, 90.00 |
Refinement procedure
Resolution | 25.725 - 1.900 |
Rwork | 0.170 |
R-free | 0.21350 |
Structure solution method | FOURIER SYNTHESIS |
RMSD bond length | 0.004 |
RMSD bond angle | 1.200 |
Data reduction software | HKL-2000 |
Data scaling software | SCALA |
Refinement software | REFMAC (5.8.0257) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 25.730 | 2.000 |
High resolution limit [Å] | 1.900 | 1.900 |
Rmerge | 0.057 | 0.370 |
Number of reflections | 33916 | 4947 |
<I/σ(I)> | 13.5 | 2.9 |
Completeness [%] | 99.9 | 99.8 |
Redundancy | 3.5 | 3.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293 | 0.1M Hepes pH 7.0, 24-28% PEG3350, 0.2M (NH4)2SO4 |